{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:28:42Z","timestamp":1790270922144,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,17]]},"DOI":"10.7759\/cureus.103776","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:46:44Z","timestamp":1771343204000},"source":"Crossref","is-referenced-by-count":2,"title":["Ceftriaxone-Induced Immune Hemolytic Anemia and Subsequent Disseminated Intravascular Coagulation"],"prefix":"10.7759","author":[{"given":"Hunter T","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kolacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery S","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"DeBruine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.73","article-title":"Drug-induced immune hemolytic anemia","author":"Garratty G","year":"2009","unstructured":"Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2009, 73-9. 10.1182\/asheducation-2009.1.73","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.903507","article-title":"Ceftriaxone-induced hemolytic anemia in a Jehovah\u2019s Witness","volume":"18","author":"Tasch J","year":"2017","unstructured":"Tasch J, Gonzalez-Zayaz P. Ceftriaxone-induced hemolytic anemia in a Jehovah\u2019s Witness. Am J Case Rep. 2017, 18:431-5. 10.12659\/AJCR.903507","journal-title":"Am J Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03321.x","article-title":"Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia","volume":"52","author":"Arndt PA","year":"2012","unstructured":"Arndt PA, Leger RM, Garratty G. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia. Transfusion. 2012, 52:602-12. 10.1111\/j.1537-2995.2011.03321.x","journal-title":"Transfusion"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000440673","article-title":"Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre","volume":"42","author":"Mayer B","year":"2015","unstructured":"Mayer B, Bartolm\u00e4s T, Y\u00fcrek S, Salama A. Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre. Transfus Med Hemother. 2015, 42:333-9. 10.1159\/000440673","journal-title":"Transfus Med Hemother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2010.06.004","article-title":"Immune hemolytic anemia associated with drug therapy","volume":"24","author":"Garratty G","year":"2010","unstructured":"Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev. 2010, 24:143-50. 10.1016\/j.blre.2010.06.004","journal-title":"Blood Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/19.088","article-title":"Ceftriaxone-induced hemolytic anemia: a rare case report","volume":"24","author":"Kumar S","year":"2020","unstructured":"Kumar S, Bansal R, Bansal P, Dhamija RK, Neurology D. Ceftriaxone-induced hemolytic anemia: a rare case report. Perm J. 2020, 24:10.7812\/TPP\/19.088","journal-title":"Perm J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1362668","article-title":"Ceftriaxone-induced severe hemolytic anemia, renal calculi, and cholecystolithiasis in a 3-year-old child: a case report and literature review","volume":"15","author":"Tao E","year":"2024","unstructured":"Tao E, Zhou H, Zheng M, et al.. Ceftriaxone-induced severe hemolytic anemia, renal calculi, and cholecystolithiasis in a 3-year-old child: a case report and literature review. Front Pharmacol. 2024, 15:1362668. 10.3389\/fphar.2024.1362668","journal-title":"Front Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20682","article-title":"An uncommon incidence of drug-induced immune hemolytic anemia secondary to ceftriaxone","volume":"13","author":"Sharma A","year":"2021","unstructured":"Sharma A, Chamberlain S, Mannuru D, Matta A. An uncommon incidence of drug-induced immune hemolytic anemia secondary to ceftriaxone. Cureus. 2021, 13:e20682. 10.7759\/cureus.20682","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8660","article-title":"Ceftriaxone-induced immune hemolytic anemia","volume":"12","author":"Singh A","year":"2020","unstructured":"Singh A, Singhania N, Sharma A, Sharma N, Samal S. Ceftriaxone-induced immune hemolytic anemia. Cureus. 2020, 12:e8660. 10.7759\/cureus.8660","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-018-0257-7","article-title":"Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature","volume":"19","author":"Leicht HB","year":"2018","unstructured":"Leicht HB, Weinig E, Mayer B, Viebahn J, Geier A, Rau M. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature. BMC Pharmacol Toxicol. 2018, 19:67. 10.1186\/s40360-018-0257-7","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s001340000598","article-title":"Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature","volume":"26","author":"Seltsam A","year":"2000","unstructured":"Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med. 2000, 26:1390-4. 10.1007\/s001340000598","journal-title":"Intensive Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/457727-ceftriaxone-induced-immune-hemolytic-anemia-and-subsequent-disseminated-intravascular-coagulation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:46:45Z","timestamp":1771343205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/457727-ceftriaxone-induced-immune-hemolytic-anemia-and-subsequent-disseminated-intravascular-coagulation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.103776","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}